These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24935470)

  • 21. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.
    Akhtar J; Priya R; Jain V; Sakhuja P; Agarwal AK; Goyal S; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
    BMC Cancer; 2020 Dec; 20(1):1175. PubMed ID: 33261560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implication of TMPRSS4 expression in human gallbladder cancer.
    Wu XY; Zhang L; Zhang KM; Zhang MH; Ruan TY; Liu CY; Xu JY
    Tumour Biol; 2014 Jun; 35(6):5481-6. PubMed ID: 24532432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of maspin mRNA as a predictor of survival in stage II and III gallbladder cancer cases.
    Baghel K; Kazmi HR; Raj S; Chandra A; Srivastava RN
    Asian Pac J Cancer Prev; 2014; 15(1):343-7. PubMed ID: 24528054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA 125: a potential tumor marker for gallbladder cancer.
    Chaube A; Tewari M; Singh U; Shukla HS
    J Surg Oncol; 2006 Jun; 93(8):665-9. PubMed ID: 16724349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer.
    Yang G; Lu Z; Meng F; Wan Y; Zhang L; Xu Q; Wang Z
    Sci Rep; 2022 Jun; 12(1):10072. PubMed ID: 35710767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
    Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
    World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?
    Kazmi HR; Chandra A; Baghel K; Singh A; Nigam J; Parmar D; Mahdi AA; Goel SK; Kumar S
    Biomed Res Int; 2014; 2014():625695. PubMed ID: 25025063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and clinicopathological significance of antiapoptotis protein survivin in gallbladder cancer.
    Gupta V; Goel MM; Chandra A; Gupta P; Kumar S; Nigam J
    Indian J Pathol Microbiol; 2016; 59(2):143-7. PubMed ID: 27166029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of CA 242 as a tumor marker in gallbladder cancer.
    Rana S; Dutta U; Kochhar R; Rana SV; Gupta R; Pal R; Jain K; Srinivasan R; Nagi B; Nain CK; Singh K
    J Gastrointest Cancer; 2012 Jun; 43(2):267-71. PubMed ID: 21573879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
    Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer.
    Wang X; Lin YK; Lu ZL; Li J
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8359-8366. PubMed ID: 32894542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients.
    Xu WY; Zhang HH; Xiong JP; Yang XB; Bai Y; Lin JZ; Long JY; Zheng YC; Zhao HT; Sang XT
    World J Gastroenterol; 2018 Aug; 24(29):3281-3292. PubMed ID: 30090008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
    Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
    World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.
    Pavlidou A; Dalamaga M; Kroupis C; Konstantoudakis G; Belimezi M; Athanasas G; Dimas K
    World J Gastroenterol; 2011 Mar; 17(12):1614-21. PubMed ID: 21472129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
    Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
    PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.